Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1125204]
Researchers:
A/Pr Mustafa Khasraw
(Principal investigator)
,
A/Pr Kerrie Mcdonald
,
A/Pr Matthew Foote
,
Dr Elizabeth Hovey
,
Dr Sonia Yip
View all 8 related researchers
Brief description Radiotherapy and Temozolomide (TMZ) chemotherapy treatment for the brain tumour glioblastoma (GBM) is not as effective in elderly patients. If their tumour has a genetic marker called "methylated MGMT", TMZ does work relatively better and is often given alone. Elderly GBM patients with this marker will be randomly selected in this trial to have TMZ alone or TMZ + Nivolumab - a drug that assists the immune system to attack cancer.
Funding Amount $AUD 1,648,862.92
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1125204
- PURL : https://purl.org/au-research/grants/nhmrc/1125204